Andrew T. Blair
Keine laufenden Positionen mehr
Profil
Andrew T.
Blair held former positions as Vice President of Clinical Research at Genzyme Corp., Proteon Therapeutics, Inc., and Vice President of Medical Affairs at Affymax, Inc. He also worked as a Principal at the University of Texas Health Center.
Blair received his undergraduate degrees from Rush University and the University of Illinois.
Ehemalige bekannte Positionen von Andrew T. Blair
| Unternehmen | Position | Ende |
|---|---|---|
| AFFYMAX, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| University of Texas Health Center | Corporate Officer/Principal | - |
| PROTARA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Andrew T. Blair
| University of Illinois | Undergraduate Degree |
| Rush University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
